Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.

By F. Khan, M. S. Virdee, C. Palmer, P. Pugh, D. O’Halloran, M. Elsik, P. Read, D. Begley, S. Fynn, D. Dutka. Journal of the American College of Cardiology, 2012

652 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/59ba7fc8ff42100e895f43ba896dd0fcf290aa30

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

Citations in the corpus

2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). (2013, methodology): “The TARgeted Left Ventricular Lead Placement to Guide Cardiac ResynchronizationTherapy (TARGET) trial randomized 220 HF patients to an LV non-apical lead position, coincident with the latest activated areas (as assessed with speckle tracking echocardiography) or to standard unguided LV lead position”
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2016, neutral): “Pacing thresholds are higher in scarred myocardium and, if possible, lead placement should avoid such regions.(294,295) Although patients with extensive scarring have an intrinsically worse prognosis, there is little evidence that they obtain less prognostic benefit from CRT.”
Myocardial strain imaging: how useful is it in clinical decision making? (2015, background): “peak radial strain value of ,10% was proposed as a marker of scar.(69)”